The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
The molecular biology of cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Alon, U., Barkai, N., Notterman, D. A., Gish, K., Ybarra, S., Mack, D., & Levine, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6745 · Cited by 4,167
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Doll, R., & Peto, R. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1192 · Cited by 3,927
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Peto, R. (1983) · The Use of Human Cells for the Evaluation of Risk from Physical and Chemical Agents · doi:10.1007/978-1-4757-1117-2_30 · Cited by 3,501
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
Earnshaw, W. C., Martins, L. M., & Kaufmann, S. H. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.383 · Cited by 2,760
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Genomics, gene expression and DNA arrays
Lockhart, D. J., & Winzeler, E. A. (2000) · Nature · doi:10.1038/35015701 · Cited by 2,053
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,845
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.
Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,780
Daley, G. Q., Van Etten, R. A., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 1,756
Browder, T. D., Butterfield, C., Kräling, B. M., Shi, B., Marshall, B., OʼReilly, M., & Folkman, J. (2000) · PubMed · Cited by 1,720
TRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Rate of depurination of native deoxyribonucleic acid
Lindahl, T., & Nyberg, B. (1972) · Biochemistry · doi:10.1021/bi00769a018 · Cited by 1,556
The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., & Wittinghofer, A. (1997) · Science · doi:10.1126/science.277.5324.333 · Cited by 1,543
Genomic analysis of metastasis reveals an essential role for RhoC
Clark, E. A., Golub, T. R., Lander, E. S., & Hynes, R. O. (2000) · Nature · doi:10.1038/35020106 · Cited by 1,445
A Restriction Point for Control of Normal Animal Cell Proliferation
Pardee, A. B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1286 · Cited by 1,415
(1991) · PubMed · Cited by 1,305
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,298
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,288
DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2
Hirao, A., Kong, Y.-Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,285
Retinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,230
Wang, J.-L., Liu, D., Zhang, Z.-J., Shan, S., Han, X., Srinivasula, S. M., Croce, C. M., Alnemri, E. S., & Huang, Z. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7124 · Cited by 1,201
Angiostatin induces and sustains dormancy of human primary tumors in mice
O'Reilly, M. S., Holmgren, L., Chen, C., & Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0696-689 · Cited by 1,184
Castaigne, S., Chomienne, C., Daniel, M., Ballerini, P., Berger, R., Fenaux, P., & Degos, L. (1990) · Blood · doi:10.1182/blood.v76.9.1704.1704 · Cited by 1,184
Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., et al. (2000) · Nature Medicine · doi:10.1038/78638 · Cited by 1,101
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Increasing complexity of Ras signaling
Campbell, S. L., Khosravi-Far, R., Rossman, K. L., Clark, G. J., & Der, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202174 · Cited by 1,079
Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044
Khwaja, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2783 · Cited by 1,039
Inhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,030
Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004
Regulation of p53 in response to DNA damage
Lakin, N. D., & Jackson, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203015 · Cited by 987
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Mirvish, S. S. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03786-v · Cited by 916
Death Signal-induced Localization of p53 Protein to Mitochondria
Marchenko, N. D., Zaika, A., & Moll, U. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16202 · Cited by 901
Reznikoff, C. A., Bertram, J. S., Brankow, D. W., & Heidelberger, C. (1973) · PubMed · Cited by 827
Self-citationGenetic susceptibility to non-polyposis colorectal cancer
Lynch, H. T., & de la Chapelle, A. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.11.801 · Cited by 814
Chk2/hCds1 functions as a DNA damage checkpoint in G1by stabilizing p53
Chehab, N. H., Malikzay, A., Appel, M., & Halazonetis, T. D. (2000) · Genes & Development · doi:10.1101/gad.14.3.278 · Cited by 805
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., et al. (1998) · Nature · doi:10.1038/25387 · Cited by 783
Understanding Ras: ‘it ain’t over ’til it’s over’
Shields, J. M., Pruitt, K., McFall, A., Shaub, A., & Der, C. J. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01740-2 · Cited by 780
Genetic instability and darwinian selection in tumours
Cahill, D. P., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01661-x · Cited by 748
Aas, T., Børresen, A.-L., Geisler, S., Smith-Sørensen, B., Johnsen, H., Varhaug, J. E., Akslen, L. A., & Lønning, P. E. (1996) · Nature Medicine · doi:10.1038/nm0796-811 · Cited by 736
Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage.
Shigenaga, M. K., Gimeno, C. J., & Ames, B. N. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9697 · Cited by 732
Risk of Second Cancers after Treatment for Hodgkin's Disease
Tucker, M. A., Coleman, C. N., Cox, R. S., Varghese, A., & Rosenberg, S. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801143180203 · Cited by 718
Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., et al. (1996) · Nature Medicine · doi:10.1038/nm0996-985 · Cited by 703
Cdc25 cell-cycle phosphatase as a target of c-myc
Galaktionov, K., Chen, X., & Beach, D. (1996) · Nature · doi:10.1038/382511a0 · Cited by 690
Hahnfeldt, P., Panigrahy, D., Folkman, J., & Hlatky, L. (1999) · PubMed · Cited by 662
MDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641
Chen, H., Lin, R. J., Xie, W., Wilpitz, D., & Evans, R. M. (1999) · Cell · doi:10.1016/s0092-8674(00)80054-9 · Cited by 637
Suppression of Malignancy by Cell Fusion
HARRIS, H., MILLER, O. J., KLEIN, G., WORST, P., & TACHIBANA, T. (1969) · Nature · doi:10.1038/223363a0 · Cited by 604
Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene
Bookstein, R., Shew, J.-Y., Chen, P.-L., Scully, P., & Lee, W.-H. (1990) · Science · doi:10.1126/science.2300823 · Cited by 591
Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
Chan, T. A., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.681 · Cited by 579
He, L.-Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/ng0298-126 · Cited by 557
Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development
Rowinsky, E. K., Windle, J. J., & Von Hoff, D. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3631 · Cited by 537
A role for Rho in Ras transformation
Qiu, R. G., Chen, J., McCormick, F., & Symons, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11781 · Cited by 533
Mitochondrion as a Novel Target of Anticancer Chemotherapy
Costantini, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.13.1042 · Cited by 532
Genomic instability in Gadd45a-deficient mice
Hollander, M. C., Sheikh, M. S., Bulavin, D. V., Lundgren, K., Augeri-Henmueller, L., Shehee, R., Molinaro, T. A., Kim, K. E., Tolosa, E., Ashwell, J. D., et al. (1999) · Nature Genetics · doi:10.1038/13802 · Cited by 510
The Regulation of Anoikis: MEKK-1 Activation Requires Cleavage by Caspases
Cardone, M. H., Salvesen, G. S., Widmann, C., Johnson, G., & Frisch, S. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80339-6 · Cited by 508
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
Swisher, S. G., Roth, J. A., Nemunaitis, J., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Connors, D. G., El-Naggar, A. K., Fossella, F., Glisson, B. S., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.9.763 · Cited by 496
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
Laird, A., Vajkoczy, P., Shawver, L. K., Thurnher, A., Liang, C., Mohammadi, M., Schlessinger, J., Ullrich, A., Hubbard, S. R., Blake, R. A., et al. (2000) · PubMed · Cited by 494
Mechanism of active transcriptional repression by the retinoblastoma protein
Weintraub, S. J., Chow, K. N. B., Luo, R. X., Zhang, S. H., He, S., & Dean, D. C. (1995) · Nature · doi:10.1038/375812a0 · Cited by 487
Jacoby, R. F., Seibert, K., Cole, C. E., Kelloff, G. J., & Lubet, R. A. (2000) · PubMed · Cited by 478
Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover
Henderson, B. R. (2000) · Nature Cell Biology · doi:10.1038/35023605 · Cited by 473
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene
Newbold, R. F., & Overell, R. W. (1983) · Nature · doi:10.1038/304648a0 · Cited by 436
Smith, M. L., Ford, J. M., Hollander, M. C., Bortnick, R. A., Amundson, S. A., Seo, Y. R., Deng, C., Hanawalt, P. C., & Fornace, A. J. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3705-3714.2000 · Cited by 432
Mehta, P. P., Bertram, J. S., & Loewenstein, W. R. (1986) · Cell · doi:10.1016/0092-8674(86)90497-6 · Cited by 408
Self-citationXERODERMA PIGMENTOSUM: BIOCHEMICAL AND GENETIC CHARACTERISTICS
Cleaver, J. E., & Bootsma, D. (1975) · Annual Review of Genetics · doi:10.1146/annurev.ge.09.120175.000315 · Cited by 397
Genetic alterations in the adenoma–carcinoma sequence
Cho, K. R., & Vogelstein, B. (1992) · Cancer · doi:10.1002/1097-0142(19920915)70:4+<1727::aid-cncr2820701613>3.0.co;2-p · Cited by 381
In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor
le Coutre, P., Mologni, L., Cleris, L., Marchesi, E., Buchdunger, E., Giardini, R., Formelli, F., & Gambacorti-Passerini, C. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.163 · Cited by 374
Rho family proteins and Ras transformation: the RHOad less traveled gets congested
Zohn, I. M., Campbell, S. L., Khosravi-Far, R., Rossman, K. L., & Der, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202181 · Cited by 352
Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma.
Knudson, A. G., Hethcote, H. W., & Brown, B. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.12.5116 · Cited by 348
Liao, D. J., & Dickson, R. B. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070143 · Cited by 343
Ames, B. N., Shigenaga, M. K., & Gold, L. S. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.93101s535 · Cited by 341
Brekken, R. A., Overholser, J. P., Stastny, V., Waltenberger, J. L., Minna, J. D., & Thorpe, P. E. (2000) · PubMed · Cited by 331
Thompson, W. J., Piazza, G. A., Li, H., Liu, L., Fetter, J. R., Zhu, B., Sperl, G. J., Ahnen, D. J., & Pamukcu, R. (2000) · PubMed · Cited by 331
Positive selection of candidate tumor-suppressor genes by subtractive hybridization.
Lee, S. W., Tomasetto, C., & Sager, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2825 · Cited by 319
The Yin-Yang of TCF/β-Catenin Signaling
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60783-6 · Cited by 291
Geographic Variation of p53 Mutational Profile in Nonmalignant Human Liver
Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., & Cerutti, P. (1994) · Science · doi:10.1126/science.8191284 · Cited by 282
Wolffe, A. P. (1997) · Nature · doi:10.1038/387016a0 · Cited by 282
Gadd45, a p53-Responsive Stress Protein, Modifies DNA Accessibility on Damaged Chromatin
Carrier, F., Georgel, P. T., Pourquier, P., Blake, M., Kontny, H. U., Antinore, M. J., Gariboldi, M., Myers, T. G., Weinstein, J. N., Pommier, Y., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1673 · Cited by 277
Allgayer, H., Babic, R., Gruetzner, K. U., Tarabichi, A., Schildberg, F. W., & Heiss, M. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2201 · Cited by 276
Jackson, A. L., & Loeb, L. A. (1998) · Genetics · doi:10.1093/genetics/148.4.1483 · Cited by 253
Critical role of Rho in cell transformation by oncogenic Ras.
Prendergast, G. C., Khosravi‐Far, R., Solski, P. A., Kurzawa, H., Lebowitz, P. F., & Der, C. J. (1995) · PubMed · Cited by 253
Antiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible With Interferon Alfa-2a
Kaban, L. B., Mulliken, J. B., Ezekowitz, R. A., Phil, D., Ebb, D., Smith, P. S., & Folkman, J. (1999) · Pediatrics · doi:10.1542/peds.103.6.1145 · Cited by 245
Branford, Hughes, & Rudzki (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01749.x · Cited by 234
Yen, L., You, X.-L., Al Moustafa, A.-E., Batist, G., Hynes, N. E., Mader, S., Meloche, S., & Alaoui-Jamali, M. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203685 · Cited by 230
The catalytic subunit of yeast telomerase
Counter, C. M., Meyerson, M., Eaton, E. N., & Weinberg, R. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9202 · Cited by 228
K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
Westra, W. H., Baas, I. O., Hruban, R. H., Askin, F. B., Wilson, K. H., Offerhaus, G. J. A., & Slebos, R. J. C. (1996) · PubMed · Cited by 223
Pegram, M. D., Konecny, G., & Slamon, D. J. (2000) · Cancer Treatment and Research · doi:10.1007/978-1-4757-3147-7_4 · Cited by 222
Control of the G1/S transition.
Reed, S. I. (1997) · PubMed · Cited by 220
RB1 gene mutations in retinoblastoma
Lohmann, D. R. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(199910)14:4<283::aid-humu2>3.0.co;2-j · Cited by 214
Repair of ultraviolet light damage in a variety of human fibroblast cell strains.
Lehmann, A. R., Kirk‐Bell, S., Arlett, C. F., Harcourt, S. A., de Weerd-Kastelein, E. A., Keijzer, W., & Hall-Smith, P. (1977) · PubMed · Cited by 210
Gu, J. H., Kagawa, S., Takakura, M., Kyo, S., Inoue, M., Roth, J. A., & Fang, B. (2000) · PubMed · Cited by 210
Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity
Volpert, O. V., Dameron, K. M., & Bouck, N. (1997) · Oncogene · doi:10.1038/sj.onc.1200977 · Cited by 210
Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer
van Steeg, H., & Kraemer, K. H. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01394-x · Cited by 209
Non-Ras targets of farnesyltransferase inhibitors: focus on Rho
Lebowitz, P. F., & Prendergast, G. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202175 · Cited by 209
Methylation, mutation and cancer
Jones, P. A., Rideout, W. M., Shen, J., Spruck, C. H., & Tsai, Y. C. (1992) · BioEssays · doi:10.1002/bies.950140107 · Cited by 202
The GADD45 Inhibition of Cdc2 Kinase Correlates with GADD45-mediated Growth Suppression
Jin, S., Antinore, M. J., Lung, F.-D. T., Dong, X., Zhao, H., Fan, F., Colchagie, A. B., Blanck, P., Roller, P. P., Fornace, A. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000284200 · Cited by 202
Retinoblastoma: a prototypic hereditary neoplasm.
Knudson, A. G. (1978) · PubMed · Cited by 199
Mitochondria: execution central
Gottlieb, R. A. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02010-x · Cited by 198
Platelet‐derived growth factor in human glioma
Westermark, B., Heldin, C., & Nistér, M. (1995) · Glia · doi:10.1002/glia.440150307 · Cited by 198
Approaches to Cancer Prevention Based on an Understanding of N-Nitrosamine Carcinogenesis
Hecht, S. S. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44168 · Cited by 198
Mitochondrial control of apoptosis: an overview
Kroemer, G. (1999) · Biochemical Society Symposia · doi:10.1042/bss0660001 · Cited by 196
Pegram, M. D., & Slamon, D. J. (1999) · PubMed · Cited by 185
Ras activation in human breast cancer
von Lintig, F. C., Dreilinger, A. D., Varki, N. M., Wallace, A. M., Casteel, D. E., & Boss, G. R. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006491619920 · Cited by 184
Regulation of p53 stability and activity in response to genotoxic stress
Colman, M. S., Afshari, C. A., & Barrett, J. C. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00035-1 · Cited by 183
Templeton, D. J., Park, S. H., Lanier, L., & Weinberg, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3033 · Cited by 180
Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells
Neve, R. M., Sutterlüty, H., Pullen, N., Lane, H. A., Daly, J. M., Krek, W., & Hynes, N. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203470 · Cited by 180
Rapid induction of senescence in human cervical carcinoma cells
Goodwin, E. C., Yang, E., Lee, C.-J., Lee, H.-W., DiMaio, D., & Hwang, E.-S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10978 · Cited by 176
Schuler, M., Rochlitz, C., Horowitz, J. A., Schlegel, J., Perruchoud, A. P., Kommoss, F., Bolliger, C. T., Kauczor, H.-U., Dalquen, P., Fritz, M. A., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.14-2075 · Cited by 166
The proto-oncogene c-myc and apoptosis
Hoffman, B., & Liebermann, D. A. (1998) · Oncogene · doi:10.1038/sj.onc.1202592 · Cited by 164
Developmental basis of retinal-specific induction of cancer by RB mutation.
Gallie, B. L., Campbell, C., Devlin, H., Duckett, A., & Squire, J. A. (1999) · PubMed · Cited by 160
Wang, S., Guo, M., Ouyang, H., Li, X., Cordon-Cardo, C., Kurimasa, A., Chen, D. J., Fuks, Z., Ling, C. C., & Li, G. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1584 · Cited by 160
Lavin, M. F. (1999) · International Journal of Radiation Biology · doi:10.1080/095530099139359 · Cited by 158
Cory, S., Vaux, D. L., Strasser, A., Harris, A. W., & Adams, J. M. (1999) · PubMed · Cited by 146
Takayama, K., Ueno, H., Nakanishi, Y., Sakamoto, T., Inoue, K., Shimizu, K., Oohashi, H., & Hara, N. (2000) · PubMed · Cited by 142
Minamoto, T., Mai, M., & Ronai, Z. A. (2000) · PubMed · Cited by 141
The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
Shih, I., Yu, J., He, T., Vogelstein, B., & Kinzler, K. W. (2000) · PubMed · Cited by 139
p53 is essential for chemotherapy-induced hair loss.
Botchkarev, V. A., Komarova, E. A., Siebenhaar, F., Botchkareva, N. V., Komarov, P. G., Maurer, M., Gilchrest, B. A., & Gudkov, A. V. (2000) · PubMed · Cited by 136
Tatsumoto, N., Hiyama, E., Murakami, Y., Imamura, Y., Shay, J. W., Matsuura, Y., & Yokoyama, T. (2000) · PubMed · Cited by 132
Rytömaa, M., Lehmann, K. E., & Downward, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203805 · Cited by 132
Watanabe, T., & Sullenger, B. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150104097 · Cited by 130
Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control
Classon, M., Salama, S. R., Gorka, C., Mulloy, R., Falter‐Braun, P., & Harlow, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190343497 · Cited by 126
The illusion of cell immortality
Hayflick, L. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1296 · Cited by 124
Claudio, P. P., Howard, C. M., Pacilio, C., Cinti, C., Romano, G., Minimo, C., Maraldi, N. M., Minna, J. D., Gelbert, L. M., Leoncini, L., et al. (2000) · PubMed · Cited by 124
Druker, B. J. (1999) · Blood · Cited by 121
O’Connell, J., Bennett, M. W., Nally, K., Houston, A. M., O’Sullivan, G. C., & Shanahan, F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06708.x · Cited by 115
Overexpression of enzymes that repair endogenous damage to DNA
Fròsina, G. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01266.x · Cited by 114
Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL
Sattler, M., & Salgia, R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00047-0 · Cited by 112
Strickland, S., Breitman, T. R., Frickel, F., Nürrenbach, A., Hädicke, E., & Sporn, M. B. (1983) · PubMed · Cited by 105
King, T. J., Fukushima, L. H., Hieber, A. D., Shimabukuro, K. A., Sakr, W., & Bertram, J. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.6.1097 · Cited by 105
Self-citationCastaigné, S., Balitrand, N., de Thé, H., Dejean, A., Degos, L., & Chomienne, C. (1992) · Blood · doi:10.1182/blood.v79.12.3110.3110 · Cited by 101
Platelet-derived growth factor expression and stimulation in human meningiomas
Black, P. M., Carroll, R. S., Głowacka, D., Riley, K. N., & Dashner, K. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.81.3.0388 · Cited by 101
Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component
Kondo, Y., Koga, S., Komata, T., & Kondo, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203538 · Cited by 98
Fas and Fas ligand interactions in malignant disease.
Owen‐Schaub, L. B., Chan, H. H. L., Cusack, J. C., Roth, J. A., & Hill, L. L. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.1.5 · Cited by 95
Expression of the RNA component of telomerase during human development and differentiation.
Yashima, K., Maitra, A., Rogers, B. B., Timmons, C. F., Rathi, A., Pınar, H., Wright, W. E., Shay, J. W., & Gazdar, A. F. (1998) · PubMed · Cited by 94
Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors.
Perletti, G., Concari, P., Giardini, R., Marras, E., Piccinini, F., Folkman, J., & Chen, L. (2000) · PubMed · Cited by 93
Suppression of Tumor Growth with Recombinant Murine Angiostatin
Wu, Z., O’Reilly, M. S., Folkman, J., & Shing, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7032 · Cited by 92
2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
Mukai, S., Kondo, Y., Koga, S., Komata, T., Barna, B. P., & Kondo, S. (2000) · PubMed · Cited by 88
Chen, C. T., Lin, J., Li, Q., Phipps, S. S., Jakubczak, J. L., Stewart, D. A., Skripchenko, Y., Forry‐Schaudies, S., Wood, J. M., Schnell, C., et al. (2000) · Human Gene Therapy · doi:10.1089/10430340050143417 · Cited by 88
Constitutively Methylated Cp G Dinucleotides as Mutation Hot Spots in the Retinoblastoma Gene (RB1)
Mancini, D. N., Singh, S. M., Ainsworth, P., & Rodenhiser, D. I. (1997) · The American Journal of Human Genetics · doi:10.1086/513898 · Cited by 87
Emerging roles of BRCA1 in transcriptional regulation and DNA repair
Chen, Y., Lee, W., & Chew, H. K. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199912)181:3<385::aid-jcp2>3.0.co;2-4 · Cited by 85
2-5A Antisense Directed against Telomerase RNA Produces Apoptosis in Ovarian Cancer Cells
Kushner, D. M., Paranjape, J. M., Bandyopadhyay, B., Cramer, H., Leaman, D. W., KENNEDY, A. W., Silverman, R. H., & Cowell, J. K. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5668 · Cited by 82
Developmental defects and tumor predisposition in Rb mutant mice
Vooijs, M., & Berns, A. J. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202999 · Cited by 82
Kagawa, S., Gu, J. H., Swisher, S. G., Ji, L., Roth, J. A., Lai, D.-T., Stephens, L. C., & Fang, B. (2000) · PubMed · Cited by 77
Chen, S., Zhu, Y., Tong, J., et al. (1991) · Blood · doi:10.1182/blood.v78.10.2696.2696 · Cited by 76
Ames, B. N., Shigenaga, M. K., & Gold, L. S. (1993) · Environmental Health Perspectives · doi:10.2307/3431840 · Cited by 73
Presence of a Kirsten Murine Sarcoma Virus ras Oncogene in Cells Transformed by 3-Methylcholanthrene
Parada, L. F., & Weinberg, R. A. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.12.2298 · Cited by 70
Bemark, M., & Neuberger, M. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203686 · Cited by 69
Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions
Bachor, C., Bachor, O. A., & Boukamp, P. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050302 · Cited by 68
Vaziri, H., & Benchimol, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203016 · Cited by 68
Tumor suppressor genes studied by cell hybridization and chromosome transfer
Anderson, M. J., & Stanbridge, E. J. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344482 · Cited by 63
Radiation, DNA damage and cancer
Hall, J. A., & Angèle, S. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01435-5 · Cited by 59
Eastham, J. A., Grafton, W. D., Martin, C. M., & Williams, B. J. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67320-x · Cited by 57
Charles S. Mott prize. The detection of environmental mutagens and potential carcinogens
Ames, B. N. (1984) · Cancer · Cited by 57
Control of apoptosis signaling by Apo2 ligand.
Sa, M., Ra, P., Jp, S., et al. (1999) · PubMed · Cited by 55
HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test.
Scheurle, D., Jahanzeb, M., Aronsohn, R. S., et al. (2000) · PubMed · Cited by 54
Is small cell lung cancer the perfect target for anti-telomerase treatment?
Sarvesvaran, J. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1649 · Cited by 54
Food constituents as a source of mutagens, carcinogens, and anticarcinogens.
Ames, B. N. (1986) · PubMed · Cited by 53
Caspase-Dependent Apoptosis Induced by Telomere Cleavage and TRF2 Loss
Multani, A. S., Özen, M., Narayad, S., Kumar, V., Chandra, J., McConkey, D. J., Newman, R. A., & Pathak, S. (2000) · Neoplasia · doi:10.1038/sj.neo.7900105 · Cited by 52
Telomerase activity in ductal carcinoma in situ and invasive breast cancer
Umbricht, C. B., Sherman, M. E., Dome, J. S., Carey, L., Marks, J., Kim, N. W., & Sukumar, S. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202714 · Cited by 52
A DNA damage signal is required for p53 to activate gadd45.
Xiao, G., Chicas, A., Olivier, M., Taya, Y., Tyagi, S., Kramer, F. R., & Bargonetti, J. (2000) · PubMed · Cited by 51
Progressive Increase in Telomerase Activity From Benign Melanocytic Conditions to Malignant Melanoma
Ramirez, R. D., D’Atri, S., Pagani, E., Faraggiana, T., Lacal, P. M., Taylor, R. S., & Shay, J. W. (1999) · Neoplasia · doi:10.1038/sj.neo.7900004 · Cited by 49
Guo, B., Cao, S., Tóth, K., Azrak, R. G., & Rustum, Y. M. (2000) · PubMed · Cited by 47
Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas
Shinoura, N., Yoshida, Y., Asai, A., et al. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700160 · Cited by 36
Apoptotic Induction in Transformed Follicular Lymphoma Cells by Bcl-2 Downregulation
Tormo, M., Tari, A. M., McDonnell, T. J., Cabanillas, F., García-Conde, J., & Lopez‐Berestein, G. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809057548 · Cited by 33
Use of Transgenic Animals in Understanding Molecular Mechanisms of Toxicity
Wolf, C. R., & Henderson, C. J. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb06889.x · Cited by 26
Microdissection, microchip arrays, and molecular analysis of tumor cells (primary and metastases)
Pappalardo, P. A., Bonner, R. F., Krizman, D. B., Emmert‐Buck, M. R., & Liotta, L. A. (1998) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(98)80047-7 · Cited by 25
Rusin, M., Butkiewicz, D., Małusecka, E., Zborek, A., Harasim, J., Czyzewski, K., Bennett, W. P., Shields, P. G., Weston, A., Welsh, J. A., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690542 · Cited by 23
Hendry, J. H. (1991) · Radiation Research · doi:10.2307/3578011 · Cited by 20
Overholt, S. M., Liu, T.-J., Taylor, D. L., Wang, M., El‐Naggar, A. K., Shillitoe, E. J., Adler‐Storthz, K., John, L. S., Zhang, W., Roth, J. A., et al. (1997) · PubMed · Cited by 18
McCormick, F. P. (1998) · Nature · doi:10.1038/28268 · Cited by 18
Second malignancies following cancer therapy
Fraser, M. C., & Tucker, M. A. (1989) · Seminars in Oncology Nursing · doi:10.1016/0749-2081(89)90022-3 · Cited by 17
Stage as major long term outcome predictor in minor salivary gland carcinoma
Lutgendorf (2000) · Pure Amsterdam UMC · doi:10.1002/1097-0142(20000915)89:6 · Cited by 1
(2000) · PubMed
(1999) · doi:10.1002/(sici)1521-1878(199912)22:1<1021::aid-bies6>3.0.co;2-p
Cited by
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
Bhutani, P., Joshi, G., Raja, N., Bachhav, N., Rajanna, P. K., Bhutani, H., Paul, A. T., & Kumar, R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01786 · Cited by 815
An overview of current delivery systems in cancer gene therapy
El-Aneed, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.013 · Cited by 693
Tyrosine kinase – Role and significance in Cancer
Paul, M. K., & Mukhopadhyay, A. K. (2004) · International Journal of Medical Sciences · doi:10.7150/ijms.1.101 · Cited by 624
Metadata
- Authors
- Bertram, J. S.
- Venue
- Molecular Aspects of Medicine
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 21
- Issue
- 6
- Pages
- 167-223
- ISSN
- 0098-2997 (ISSN-L)
- OpenAlex
- W2095510701
- Cited by
- 585
- References
- 195
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.